Ultimate Breakout – Alan Green talks #IMM, #MSMN and #HREE with Justin at Breakout Capital Ventures
Alan Green discusses: ImmuPharma #IMM Mosman Oil & Gas #MSMN Harena Resources #HREE with Justin at Breakout Capital Ventures
Stockbox podcast with Alan Green, Mark Fairbairn and Dan Flynn covers #ONDO, #GFIN, #OTB, #OMI, #IMM & #EGT
On this week’s Stockbox podcast with Alan Green, Mark Fairbairn and Dan Flynn, we discuss: Ondo Insurtech #ONDO Gfinity #GFIN On The Beach #OTB Orosur Mining #OMI Immupharma #IMM European Green Transition #EGT
Tim McCarthy , Non-Executive Chairman of ImmuPharma (AIM:IMM) Interviewed on ShareTalk
ImmuPharma focuses on developing pioneering and novel drugs in specialist therapeutic areas. We are an ethical organisation with the vision to develop novel drugs to treat serious medical conditions, delivering value to patients, medical professionals, healthcare payers and our shareholders. We value innovation, creativity, integrity, fairness, competency, professionalism, and we have a passion for what […]
Brand CEO Alan Green talks ImmuPharma #IMM, Lanstead Investors, #KAZ Minerals & #URA Holdings on VOX Markets podcast
Brand CEO Alan Green talks ImmuPharma #IMM, Lanstead Investors, #KAZ Minerals & #URA Holdings with Justin Waite on the VOX Markets podcast. Interview is 30 minutes 15 seconds in.
Brand CEO Alan Green talks gigs, Watchstone (WTG), Hemogenyx (HEMO) & Immupharma (IMM) on Vox Markets podcast
Brand CEO Alan Green talks gigs, Watchstone Group (WTG), Hemogenyx (HEMO) & Immupharma (IMM) with Justin Waite on the Vox Markets podcast. The interview is 23 minutes in.
Buy Immupharma (IMM) says VectorVest. This pharma stock still offers further upside for the adventurous investor.
AIM listed ImmuPharma (IMM.L) is a drug discovery and development company. The London-based Company is focused on the development of drugs, primarily based on peptide therapeutics, to treat serious medical conditions such as autoimmune diseases. IMM has approximately five drug candidates in development, over two platform technologies and approximately 70 patents. Lupuzor is the Company’s […]